Tempus announces multicentre validation of AI-enabled ECG model for predicting AF risk
Tempus has announced the publication of successful multi-site validation of its artificial intelligence (AI)-enabled electrocardiogram (ECG) software, which received US Food and Drug Administration...
Medtronic announces strategic investments in ICE catheter technologies
Medtronic has announced strategic investments in two privately held companies focused on the development of intracardiac echocardiography (ICE) catheter technologies, which provide real-time, high-resolution...
Accurkardia granted patent for AI-driven ECG detection of cardiac amyloidosis
Accurkardia has announced that it has been granted US patent number 12,620,488 for the company's proprietary machine learning-based system for identifying cardiac amyloidosis from...
Rhythm AI appoints medtech veteran Mike Dineen as new CEO
Rhythm AI, developer of the Star Apollo mapping software, has announced the appointment of Mike Dineen as chief executive officer (CEO). Dineen brings more than 30...
